OVERVIEW

Tesamorelin 5mg is a synthetic peptide and a growth hormone–releasing hormone (GHRH) analog that stimulates the pituitary gland to produce growth hormone naturally. By promoting pulsatile growth hormone release, Tesamorelin supports tissue repair, metabolism, and lean muscle development. It has been studied extensively for its potential to reduce visceral fat, improve body composition, and enhance recovery in research settings. Unlike direct growth hormone therapy, Tesamorelin encourages the body to regulate hormone levels naturally, which may reduce the risk of overstimulation or side effects associated with exogenous growth hormone. Its mechanism of action involves signaling the pituitary to release growth hormone in a controlled manner, supporting both metabolic and regenerative processes.

The 5mg dosage of Tesamorelin is typically supplied as a lyophilized powder for research or experimental use and requires reconstitution with bacteriostatic water prior to administration. Preclinical and early clinical studies suggest it may improve lean muscle mass, promote fat metabolism, and enhance post-exercise or injury recovery. Potential side effects can include injection site irritation, flushing, headaches, or temporary changes in blood glucose levels. Tesamorelin is not approved for general medical use outside specific regulatory indications, and its use should be guided by a qualified healthcare professional. Careful dosing, monitoring, and adherence to research protocols are essential to ensure safe and effective results.